UPDATE : Wednesday, October 23, 2019
상단여백
‘Korean hospitals equipped well to use CAR-T therapy’ by Kim Yun-mi 2019-10-23 13:17
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent by Kim Yun-mi 2019-10-22 14:17
Merck Korea forcefully shuts down general medicine biz by Kim Yun-mi 2019-10-15 15:51
Galderma Korea’s key strategy: choice and concentration by Kim Yun-mi 2019-10-15 13:56
[Special] How are Korean employees coping with big-pharma M&As? by Kim Yun-mi 2019-10-14 13:45
라인
Sanofi to cover part of Dupixent cost for atopic dermatitis patients by Kim Yun-mi 2019-10-11 15:13
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’ by Kim Yun-mi 2019-10-10 16:01
Medtronic Korea denies regulatory negligence over recalled insulin pumps by Kim Yun-mi 2019-10-08 15:05
Galderma Korea workers feel insecure after separation from Nestle by Kim Yun-mi 2019-10-07 14:38
CDK4/6 inhibitor+fulvestrant combo nears getting benefit by Kim Yun-mi 2019-10-02 16:03
라인
‘Merck Korea unilaterally lays off employees’ by Kim Yun-mi 2019-10-01 11:09
Pfizer’s leukemia therapy Besponsa to get insurance benefit by Kim Yun-mi 2019-09-26 11:26
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’ by Kim Yun-mi 2019-09-23 11:45
Takeda Korea labor union to ask Japanese headquarters about restructuring by Kim Yun-mi 2019-09-19 14:11
Korea unlikely to include hepatitis C test in state-backed health checkup by Kim Yun-mi 2019-09-18 15:50
라인
Will Tagrisso study results affect use of EGFR TKIs in lung cancer? by Kim Yun-mi 2019-09-18 11:36
‘Lundbeck to work with parliament to prevent suicide in Korea’ by Kim Yun-mi 2019-09-17 15:19
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma by Kim Yun-mi 2019-09-16 16:20
FDA warns against pneumonitis with CDK 4/6 inhibitor drugs for breast cancer by Kim Yun-mi 2019-09-16 11:39
AstraZeneca to challenge Roche in small-cell lung cancer treatment market by Kim Yun-mi 2019-09-11 14:18
여백
여백
여백
Back to Top